These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 37520302)
1. Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer. Wang Z; Qin Y; Wang X; Zhang T; Hu Y; Wang D; Zhang L; Zhu Y Int J Nanomedicine; 2023; 18():4023-4042. PubMed ID: 37520302 [TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of photodynamic therapy and chemotherapy: Activating the intrinsic/extrinsic apoptotic pathway of anoikis for triple-negative breast cancer treatment. Zhang T; Wang X; Wang D; Lei M; Hu Y; Chen Z; Li Y; Luo Y; Zhang L; Zhu Y Biomater Adv; 2024 Jun; 160():213859. PubMed ID: 38642515 [TBL] [Abstract][Full Text] [Related]
3. Mitochondria Targeting and Destabilizing Hyaluronic Acid Derivative-Based Nanoparticles for the Delivery of Lapatinib to Triple-Negative Breast Cancer. Lee SY; Cho HJ Biomacromolecules; 2019 Feb; 20(2):835-845. PubMed ID: 30566834 [TBL] [Abstract][Full Text] [Related]
4. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859 [TBL] [Abstract][Full Text] [Related]
5. Antitumor Effect of Lonidamine-Polypeptide-Peptide Nanoparticles in Breast Cancer Models. Cohen-Erez I; Issacson C; Lavi Y; Shaco-Levy R; Milam J; Laster B; Gheber LA; Rapaport H ACS Appl Mater Interfaces; 2019 Sep; 11(36):32670-32678. PubMed ID: 31414594 [TBL] [Abstract][Full Text] [Related]
6. TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells. Wang DF; Rong WT; Lu Y; Hou J; Qi SS; Xiao Q; Zhang J; You J; Yu SQ; Xu Q ACS Appl Mater Interfaces; 2015 Feb; 7(7):3888-901. PubMed ID: 25644220 [TBL] [Abstract][Full Text] [Related]
7. Negatively charged polypeptide-peptide nanoparticles showing efficient drug delivery to the mitochondria. Cohen-Erez I; Rapaport H Colloids Surf B Biointerfaces; 2018 Feb; 162():186-192. PubMed ID: 29190470 [TBL] [Abstract][Full Text] [Related]
8. Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer. Scully MA; Wilkins DE; Dang MN; Hoover EC; Aboeleneen SB; Day ES Mol Pharm; 2023 Aug; 20(8):3895-3913. PubMed ID: 37459272 [TBL] [Abstract][Full Text] [Related]
9. Effective Antitumor of Orally Intestinal Targeting Penetrating Peptide-Loaded Tyroserleutide/PLGA Nanoparticles in Hepatocellular Carcinoma. Ma C; Wei T; Hua Y; Wang Z; Zhang L Int J Nanomedicine; 2021; 16():4495-4513. PubMed ID: 34239301 [TBL] [Abstract][Full Text] [Related]
10. Combined Photosensitive Gene Therapy Effective Against Triple-Negative Breast Cancer in Mice Model. Hu Y; Wang D; Zhang T; Lei M; Luo Y; Chen Z; Li Y; Duan D; Zhang L; Zhu Y Int J Nanomedicine; 2024; 19():1809-1825. PubMed ID: 38414523 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial-Targeting Lonidamine-Doxorubicin Nanoparticles for Synergistic Chemotherapy to Conquer Drug Resistance. Liu Y; Zhang X; Zhou M; Nan X; Chen X; Zhang X ACS Appl Mater Interfaces; 2017 Dec; 9(50):43498-43507. PubMed ID: 29171954 [TBL] [Abstract][Full Text] [Related]
12. A mitochondria-targeting self-assembled carrier-free lonidamine nanodrug for redox-activated drug release to enhance cancer chemotherapy. Yang T; Zhang X; Yang X; Li Y; Xiang J; Xiang C; Liu Z; Hai L; Huang S; Zhou L; Liang R; Gong P J Mater Chem B; 2023 May; 11(17):3951-3957. PubMed ID: 37067569 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and evaluation of in vitro cytotoxicity and in vivo antitumor activity of asiatic acid-loaded poly lactic-co-glycolic acid nanoparticles: A strategy of treating breast cancer. Dutta S; Chakraborty P; Basak S; Ghosh S; Ghosh N; Chatterjee S; Dewanjee S; Sil PC Life Sci; 2022 Oct; 307():120876. PubMed ID: 35961595 [TBL] [Abstract][Full Text] [Related]
14. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma. Srivastava S; Gupta S; Mohammad S; Ahmad I J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208 [TBL] [Abstract][Full Text] [Related]
15. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer. Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759 [TBL] [Abstract][Full Text] [Related]
16. Mitochondria apoptosis pathway synergistically activated by hierarchical targeted nanoparticles co-delivering siRNA and lonidamine. Zhang BF; Xing L; Cui PF; Wang FZ; Xie RL; Zhang JL; Zhang M; He YJ; Lyu JY; Qiao JB; Chen BA; Jiang HL Biomaterials; 2015 Aug; 61():178-89. PubMed ID: 26004233 [TBL] [Abstract][Full Text] [Related]
17. Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitors in triple-negative breast cancer cell line. Byrne CE; Astete CE; Vaithiyanathan M; Melvin AT; Moradipour M; Rankin SE; Knutson BL; Sabliov CM; Martin EC Nanomedicine (Lond); 2020 Apr; 15(10):981-1000. PubMed ID: 32238059 [No Abstract] [Full Text] [Related]
18. Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer. Niu M; Valdes S; Naguib YW; Hursting SD; Cui Z Mol Pharm; 2016 Jun; 13(6):1833-42. PubMed ID: 27074028 [TBL] [Abstract][Full Text] [Related]
19. Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells. Bressler EM; Kim J; Shmueli RB; Mirando AC; Bazzazi H; Lee E; Popel AS; Pandey NB; Green JJ J Biomed Mater Res A; 2018 Jun; 106(6):1753-1764. PubMed ID: 29424479 [TBL] [Abstract][Full Text] [Related]
20. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles. Metin E; Mutlu P; Gündüz U Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]